A detailed history of Goldman Sachs Group Inc transactions in Celcuity Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 100,703 shares of CELC stock, worth $1.34 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100,703
Previous 22,633 344.94%
Holding current value
$1.34 Million
Previous $370,000 305.68%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$13.98 - $19.15 $1.09 Million - $1.5 Million
78,070 Added 344.94%
100,703 $1.5 Million
Q2 2024

Aug 13, 2024

BUY
$14.1 - $20.78 $319,125 - $470,313
22,633 New
22,633 $370,000
Q4 2023

Feb 13, 2024

SELL
$8.7 - $15.02 $2,957 - $5,106
-340 Reduced 2.41%
13,743 $200,000
Q3 2023

May 14, 2024

BUY
$8.96 - $10.75 $3,046 - $3,655
340 Added 2.47%
14,083 $128,000
Q3 2023

Nov 14, 2023

BUY
$8.96 - $10.75 $116 - $139
13 Added 0.09%
14,083 $128,000
Q2 2023

May 14, 2024

SELL
$9.39 - $12.18 $291,606 - $378,249
-31,055 Reduced 68.82%
14,070 $154,000
Q2 2023

Aug 14, 2023

SELL
$9.39 - $12.18 $291,606 - $378,249
-31,055 Reduced 68.82%
14,070 $154,000
Q1 2023

May 14, 2024

BUY
$9.4 - $12.82 $294,990 - $402,317
31,382 Added 228.35%
45,125 $462,000
Q1 2023

May 11, 2023

BUY
$9.4 - $12.82 $424,175 - $578,502
45,125 New
45,125 $462,000
Q4 2021

Feb 14, 2022

SELL
$11.96 - $19.35 $126,967 - $205,419
-10,616 Closed
0 $0
Q3 2021

Nov 10, 2021

BUY
$17.35 - $24.87 $184,187 - $264,019
10,616 New
10,616 $191,000

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $198M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.